ARTICLE | Clinical News
Canopus preclinical data
June 23, 2008 7:00 AM UTC
In mouse models of lung cancer, CB1400 plus cisplatin inhibited tumor growth by 70% vs. 62% for CB1400 alone and 49% for cisplatin alone. In a separate mouse study, CB1400 plus Erbitux cetuximab inhi...